nicardipine has been researched along with No-Reflow Phenomenon in 3 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
No-Reflow Phenomenon: Markedly reduced or absent REPERFUSION in an infarct zone following the removal of an obstruction or constriction of an artery.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nicardipine was administered as a 200 μg IC bolus, after which repeat angiography was performed." | 1.51 | The Spontaneous Coronary Slow-Flow Phenomenon: Reversal by Intracoronary Nicardipine. ( Finley, JJ; Fischman, DL; McCarey, M; Mehta, HH; Morris, M; Ruggiero, N; Savage, MP; Walinsky, P, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehta, HH | 1 |
| Morris, M | 1 |
| Fischman, DL | 1 |
| Finley, JJ | 1 |
| Ruggiero, N | 1 |
| Walinsky, P | 1 |
| McCarey, M | 1 |
| Savage, MP | 1 |
| Kiernan, TJ | 1 |
| Ruggiero, NJ | 1 |
| Bernal, JM | 1 |
| Don, CW | 1 |
| Witzke, C | 1 |
| Kiernan, GD | 1 |
| Cubeddu, RJ | 1 |
| Yan, BP | 1 |
| Habibzadeh, MR | 1 |
| Thai, H | 1 |
| Movahed, MR | 1 |
2 reviews available for nicardipine and No-Reflow Phenomenon
| Article | Year |
|---|---|
The no-reflow phenomenon in the coronary circulation.
Topics: Adenosine; Animals; Coronary Circulation; Diltiazem; Humans; Nicardipine; Nicorandil; Nitroprusside; | 2009 |
Prophylactic intragraft injection of nicardipine prior to saphenous vein graft percutaneous intervention for the prevention of no-reflow: a review and comparison to protection devices.
Topics: Angioplasty, Balloon, Coronary; Catheterization; Coronary Artery Bypass; Embolic Protection Devices; | 2011 |
1 other study available for nicardipine and No-Reflow Phenomenon
| Article | Year |
|---|---|
The Spontaneous Coronary Slow-Flow Phenomenon: Reversal by Intracoronary Nicardipine.
Topics: Adult; Angina Pectoris; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Coronary Circ | 2019 |